Repligen Corp. (RGEN)
131.21
+4.12
(+3.24%)
USD |
NASDAQ |
Apr 17, 16:00
130.48
-0.73
(-0.56%)
After-Hours: 06:55
Repligen SG&A Expense (Quarterly) : 74.36M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Masimo Corp. | 131.30M |
| Orthofix Medical, Inc. | 136.75M |
| InfuSystem Holdings, Inc. | 16.51M |
| Tandem Diabetes Care, Inc. | 113.10M |
| Plus Therapeutics, Inc. | 4.168M |